What's new

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive

Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive

Feb 20, 2025 - 15:02
 0
Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive
Orphan designation: Elraglusib Treatment of soft tissue sarcoma, 16/01/2025 Positive
Read More

Tags:

Previous Article

Orphan designation: Allogenic umbilical cord-derived osteoblast cells Treatment ...

Next Article

What’s new in naval tech? Highlights from WEST 2025

Related Posts

Certificates Processing System: Demo & Q&A session for Industry stakeholders (H+V), Online, from 27 March 2025, 12:30 (CET) to 27 March 2025, 13:00 (CET)

Certificates Processing System: Demo & Q&A session for ...

Feb 28, 2025  0

Human medicines European public assessment report (EPAR): Veoza, fezolinetant, Date of authorisation: 07/12/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 14, 2025  0

Submission deadlines for orphan designations

Submission deadlines for orphan designations

Feb 9, 2025  0